Direct Health Care Costs of Diabetic Patients in Spain

摘要: OBJECTIVE—The goal of this study was to estimate the health care resources spent by type 1 and 2 diabetic patients in Spain during year 2002. RESEARCH DESIGN AND METHODS—This is a cost-of-illness focusing on direct costs estimated from primary secondary sources information. A prevalence diabetes ranging 5 6% adult population determined. Total cost composed six items: insulin oral hypoglycemic agents, other drugs, disposable consumable goods (glucose test strips, needles, syringes), hospitalization, visits, visits endocrinologists dialysis. RESULTS—The 2002 ranges €2.4 2.67 billion. Hospital were most (€933 million), followed noninsulin, nonhypoglycemic agent drugs (€777–932 million). Much lower are agents (€311 (€181–272 specialized (€127–145 elements (€70–81 Expenditures for all ranged between €1.16 1.3 billion, representing 48–49% total cost, which 15% higher than hospital costs. CONCLUSIONS—The high (6.3–7.4% National Health System expenditure). Their average annual €1,290–1,476. For individuals without diabetes, €865.